[Social phobia].
With a lifetime prevalence of 13% social phobia (social anxiety disorder) is a common and serious condition that should not be played down because of the burden associated with the disorder, an increased suicide rate and the frequent comorbidity with substance abuse disorders. Social phobia is characterized by the excessive and unrealistic fear of being scrutinized or criticized by others. The disorder often begins in adolescence.Symptoms of social phobia can be effectively treated with evidence-based treatment, including cognitive behavior therapy (CBT) and psychopharmacological medications. In the present paper, treatment recommendations are given, which are based on a systematic review of all available randomized trials for the treatment of social phobia. Among psychological therapies, variants of CBT have been proven to be effective in controlled studies. Selective serotonin reuptake inhibitors (SSRIs) and the selective serotonin norepinephrine reuptake inhibitor (SNRI) venlafaxine are among the drugs of first choice.
Klinik für Psychiatrie und Psychotherapie, Universitätsmedizin Göttingen, von-Siebold-Str. 5, 37075, Göttingen, Deutschland, Sekretariat.Bandelow@med.uni-goettingen.de.
B
B
Bandelow
D
D
Wedekind
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003511:Cyclohexanols / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D010698:Phobic Disorders / Q000175:diagnosis / Q000523:psychology* / Q000628:therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride